Clinical Trial Update: Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a four-drug combination of everolimus, pemetrexed, carboplatin, and bevacizumab for stage IV non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Everolimus (everolimus)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Cancer Research and Biostatistics Clinical Trials Consortium | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED